Bone Grafts and Substitutes Market to reach USD 3.48 billion in 2023

With only a few companies enjoying dominance, the global bone grafts and substitutes market demonstrates a consolidated vendor landscape. As per Transparency Market Research (TMR), the top three companies including Stryker Corporation, Zimmer, and Medtronic accounted for over 50% of the market in 2014. “The key market players are in a constant competitive state as they vie for sustainable growth and increasing their global footprint,” said a lead TMR analyst 

Manufacturers operating in the global bone grafts and substitutes market have shown interest in signing long-term contracts with dental clinics and hospitals in order to maintain their sales and service relationships. They frequently offer additional services to strengthen their relationship with buyers and enjoy sustainable growth. Besides this, the companies are also exploring acquisition opportunities to expand their geographic presence.The global bone graft and substitutes market is projected to exhibit a CAGR of 4.5% between 2015 and 2023. The market stood at US$2.35 bn in 2014 and is expected to reach US$3.48 bn by the end of 2023. 

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6200

Rising Prevalence of Bone Disorders Fuels Demand for Bone Grafts and Substitutes

The rising prevalence of bone and joint disorders will significantly fuel demand for bone grafts and substitutes. According to the Centers for Disease Control and Prevention (CDC) over 67 million people in the U.S. alone are likely to be diagnosed with arthritis by 2030. Besides this, arthritis is also considered one of the leading causes of disability affecting millions around the world. The situation has proven quite favorable for the market in terms of bolstering demand for joint and reconstructive bone surgery. This in turn translates into high demand for bone grafts and substitutes.

The dramatic rise in the number of orthopedic surgeries is also expected to aid the market’s expansion. In developing countries, the bone grafts and substitute manufacturers are expected to capitalize on the increasing medical tourism. As per TMR, in the last couple of years, India, China, Malaysia, Japan, and Mexico have emerged as key destinations for affordable treatment attracting people from across the globe. The number of people visiting these nations for orthopedic and dental surgeries has spiked considerably, thus boosting bone grafts and substitutes sales. 

Ethical Issues Rising from Gaps between Demand and Supply of Allografts to Inhibit Market

Reports of post implantation infections have been creating bottlenecks for the market. The market is also inhibited by implant failures on various occasions. “Obtaining allografts from donors and preserving them give rise to various ethical issues related to storing and harvesting them,” said a TMR analyst. Such long gestation periods between demand and supply of allografts may give rise to ethical issues. Hence stringent regulations have been implemented on the usage of bone grafts and substitutes aimed at curbing the prevalence of malpractices that increase the risk of infection. This in turn is limiting the market’s trajectory to an extent.

Nevertheless, the rising geriatric population and the increasing disposable income will create new growth opportunities for the market in the near future. Furthermore, the market will also gain from the increasing healthcare expenditure, which will in turn encourage the entry of new players.

The market was dominated by the spinal fusion application segment in 2014. It is expected to rise at a CAGR of 4.4% during the forecast period. Regionally, North America dominated the global bone graft and substitute market in 2014. Several key players are domiciled in the region. This combined with rising geriatric population will enable the North America market to reach US$1.23 bn by the end of 2023.

Browse Research Report on Global Bone Grafts and Substitutes Market:
http://www.transparencymarketresearch.com/bone-grafts-substitutes-market.html

Compression Therapy Market will exhibit a CAGR of 5.3% between 2016 and 2024

Inadequate regulations for the commercialization of products and forward integration by raw material suppliers have kept the threat of new entrants high in the global compression therapy market, finds Transparency Market Research in a new study. This, combined with presence of a large number of local and global players, renders the market highly fragmented. Suppliers in the market also don’t enjoy a high bargaining power due to their presence in large numbers.

Transparency Market Research forecasts the global compression therapy market to reach US$4.25 bn by 2024 from a valuation of US$2,693.4 mn in 2015. If these figures hold true, the market will exhibit a CAGR of 5.3% between 2016 and 2024.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1537

The majority of the companies operating in the market are vying to emerge dominant through mergers and acquisitions. They are also witnessing attractive prospects in the emerging economies of Asia Pacific. TMR recommends that adopting collaborative strategies could help these companies capitalize on untapped opportunities in the region. With the population in China, Japan, Singapore, and South Korea increasing at a rapid pace, combined with their increasing interest in sports and fitness, manufacturers of compression therapy products stand chance to gain a competitive edge in the market.

Capitalizing on Untapped Opportunities in Emerging Economies Could Boost Market

TMR finds that the ripest opportunities lie in emerging economies of Latin America and Asia Pacific. “Immense potential for healthcare products in countries such as South Korea, Brazil, China, Mexico, and India will prove to be lucrative for companies vying for sizeable share in the global compression therapy market,” said a TMR analyst. “Due to the increasing investment on the healthcare infrastructure, increasing disposable income, and the rising incidence of chronic ailments, these regions exhibit robust prospects for the compression therapy market,” he added.

In the last few years, compression therapy has emerged as one of the most preferred procedures for treating sports related injuries. The growth witnesses by the market therefore corresponds directly to the growing popularity for sports worldwide. Besides this, the rising prevalence of obesity and increase in the number of orthopedic surgeries also create ample opportunities favoring the market’s expansion.

Absence of Reimbursement Regulations to Negatively Impact Sales of Compression Therapy Products

Despite growth prospects for the market being robust, the absence of proper reimbursement will have an adverse impact on its growth trajectory. Nevertheless, the increasing investment on the development of the healthcare infrastructure in developing companies will provide considerable opportunities for vendors to boost their sales.

Presently, the market has been witnessing lucrative prospects for the sale of static compression products. Supported by clinical evidence, static garments are preferred more by doctors as patient care products. Additionally, patients favor static compression hosiery more since it is made with comfortable material and due to its aesthetic appeal.

North America Exhibits Highest Prospects for Compression Therapy

Regionally, the prospects for compression therapy seem most lucrative in North America. The region held over 47.2% of the global compression therapy market in 2015, followed by Europe, which accounted for a share of 32.2% in the market. Obesity being a widespread problem in developed economies such as the U.S., North America will be witnessing a high incidence of vascular diseases. This is evidently proving favorable for enterprises offering compression therapy products to maximize their sales.

Browse Research Report on Global Compression Therapy Market:
http://www.transparencymarketresearch.com/compression-therapy-market.html

Ambulatory Surgical Centers Growing Popularity Stimulates Demand for Operating Room Equipment Market

About 42% of the global operating room equipment market was in the hands of a large number of regional players in 2014, finds Transparency Market Research (TMR) in a new study. This highly fragmented market witnesses a towering presence of about five key players – including Siemens Healthcare, Stryker Corporation, and GE Healthcare – that hold significant shares from the remainder. GE Healthcare, for instance, held close to 19% of the operating room equipment revenues in 2014, which was the single largest in that year.

According to Transparency Market Research, all key players are showing a common trait of heavy investments in research and development in operating room equipment innovations. Successful innovations have allowed these players to maintain major revenue shares for the time being.

The global operating room equipment market is expanding at a CAGR of 6.68% within a forecast period from 2015 to 2023. This market will be valued above US$42 bn in 2023, after being recorded around US$24 bn in 2014. A major contribution to this growth rate is made by the movable imaging products segment, which is progressing at a CAGR of 8.20% within the same forecast period.

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1674

Push for Ambulatory Surgical Centers Expected to Propel Operating Room Equipment Demand

Ambulatory surgical centers (ASCs) are a relatively modern approach towards out-patient surgical solutions. They cater specifically to those surgical procedures that do not require a patient to stay overnight in a hospital.

“In the U.S., in 2012, there were more than 5,000 Medicare-approved ASCs, as the Centers of Medicare and Medicaid Services had revealed. There was a rise in 24% for the Medicare payments made to ASCs between 2007 and 2012,” explains a TMR analyst. “This establishes the already set importance of ASCs in developed economies, and the demand for ASCs is only expected to grow even further over the coming years,” she adds. As a result, vendors of operating room equipment are expected to find a high scope of growth in similar regions.

Players Can Look to APAC and LATAM for Bigger Opportunities

High population density and rapidly improving healthcare infrastructure are the two biggest reasons for globally present companies for operating room equipment to find sustainable options in the Asia Pacific and Latin America regions. “This applies especially to India, where the rapid growth of multispecialty hospitals is creating a high demand for hybrid operating rooms. Fortis Healthcare, Wockhardt Hospitals, and Apollo Hospitals, to name a few, are where entrants to Asia Pacific can look to,” says the analyst.

Additionally, the massive presence of an overseas patient pool due to the rise of medical tourism is creating an optimistic scope of growth for both hospitals and operating room equipment sales. In the case of Brazil, Mexico, and other Latin American countries hold a high percentage of unmet medical needs. This gap in supply and demand, coupled with the growing healthcare expenditure through improved disposable incomes of patients will be beneficial for the proliferation of operating room equipment providers in the region.

The above data is collated from a research report released by TMR, titled “Operating Room Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015–2023.”

Browse Research Report on Global Operating Room Equipment Market:
http://www.transparencymarketresearch.com/operating-room-equipment-market.html

Image Guided Surgery Devices Market Advances with Improvement in Technology, Public Awareness; Market to Reach US$4.8 bn in 2022

A new Transparency Market Research report states that the global image guided surgery devices market, which was pegged at US$2.76 bn in 2013, is predicted to reach US$4.80 bn in 2022, expanding at a CAGR of 6.40% from 2014 to 2022. The title of the report is “Image Guided Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.”

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2541
 
Image guided surgery is a term utilized for any type of surgical procedure wherein the surgeon utilizes tracked surgical instruments coupled with intraoperative and preoperative images for indirect guidance for the procedure. Image guided surgery systems utilize electromagnetic fields or cameras for capturing and relaying images of the anatomy of patients. Image guided surgery is used in a wide range of applications and is particularly utilized in surgery of the sinuses, where it aids in avoiding damage to the nervous system and the brain of the patient.

As per the report, the increasing demand for enhanced healthcare facilities and the rising healthcare expenditure globally are amongst the chief factors fuelling the market for image guided surgery devices. In addition, the rising popularity of IGS devices and the increasing initiatives taken by governments globally will also have a positive impact on the growth of the market. Furthermore, the developing markets hold a significant potential for the image guided surgery devices, hence propelling market development. The increasing count of partnerships and collaborations is a key trend seen in the market. On the other hand, the absence of skilled professionals and the soaring cost of installation of image guided surgery devices are amongst the major factors inhibiting the development of the market. In addition, the stringent regulatory needs and the lack of health insurance in emerging countries will also pose a negative impact on the growth of the market.

On the basis of device type, the report segments the market into ultrasound, computed tomography (CT) scanners, magnetic resonance imaging (MRI) machine, x-ray fluoroscopy machine, endoscope, single photon emission computed tomography (SPECT) equipment, and positron emission tomography (PET) machine. Amongst these, computed tomography (CT) scanners have the highest demand owing to the increasing applications of CT scanners in tumor detection and imaging of soft tissue structures. In addition¸ the turnaround time of these scanners is less, which is advantageous in critical and complicated surgeries. This segment stood at US$770 mn in 2013.

In terms of application, the report segments the market into orthopedic surgery, neurosurgery, oncology surgery, ear, nose, and throat surgery, and others. Amongst these, the segment of neurosurgery held the largest share in the market in 2013. The increasing accuracy of operating procedures is a key factor fuelling the growth of the neurosurgery segment. On the other hand, the demand for orthopedic image guided surgeries is also predicted to rise owing to the increasing aging population and the increasing occurrence of road accidents globally.

On the basis of geography, the report segments the market into Europe, North America, Latin America, Asia Pacific, the Middle East, and Rest of the World (RoW). Amongst these, North America led the market in 2013 and was trailed by Europe. The reasons for the superiority of both these regions include the increasing adoption rate of new technologies, the increasing healthcare expenditure, and the availability of trained healthcare professionals in these regions.

As per the report, the chief players dominant in the market are Toshiba Corporation, Siemens Healthcare, Koninklijke Philips N.V., St. Jude Medical, Inc., General Electric Company, Medtronic plc, Brainlab AG, and Varian Medical Systems, Inc., among others.

Browse Research Report on Global Image Guided Surgery Devices Market:
http://www.transparencymarketresearch.com/image-guided-surgery.html

Global Urgent Care Centers Market to Reach US$30.5 bn by 2020

The global urgent care centers (UCCs) market has several private companies operating urgent care chains in the market such as AFC/Doctors Express, FastMed Urgent Care, MD Now, Concentra Inc., CareSpot Express Healthcare LLC, MedExpress, MinuteClinic LLC, NextCare Urgent Care, Pateint First and U.S. HealthWorks Inc. Also, a large number of small market players are trying to enter and establish in the urgent care centers market. This has resulted in a highly fragmented market for UCCs industry with large number of urgent care chains accounting for less than 1% of the total market. Moreover, many private insurance firms are also becoming attracted towards the UCCs market. 

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2254

Cost Effective Visits and Faster Service Maintain UCCs on the Growth Front

Urgent care centers provide immediate care services to patients with minor injuries. The service time and quality of health care services in a UCC are better than that in an emergency department (ED). Additionally, the fee per visit paid by a patient, whether with health insurance or not, in UCCs is much lower than the fee paid in EDs. These advantages of UCCs over EDs are expected to increase the number of visits to UCCs, thus driving the growth of the global urgent care centers (UCCs) market.

Moreover, appointment flexibility provided by UCCs coupled with reduced waiting time has increased their popularity amongst patients. A surge in the population of insured people is also driving the urgent care centers market. The considerably low cost of treatment is attracting a large pool of insured patients. Furthermore, the growth of UCCs is backed by many private and public investors, thus increasing the pace of growth of urgent care centers exponentially.

Unavailability of Physicians Likely to Harm Visits to Urgent Care Centers

Continued shortages in the number of physicians are likely to limit the growth of the market and it will worsen in the next few years according to the Urgent Care Association of America (UCAOA) survey report. This can adversely affect the growth of the UCCs market. However, the effect of this restraint could be alleviated with physician assistants and nursing practitioners compensating this deficiency to some extent.

Another impediment to the growth of the UCCs market is the high initial cost required for the set-up of the urgent care centers. Apart from the establishment costs, a large number of patient visits per week are required to meet the huge operational costs of UCCs.

North America Leads With a Substantial Margin Owing to High Adoption Rate of UCCs

By geography, the global UGCs market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). North America, which was the leading segment by value in 2013, is anticipated to retain its leadership with a share of 73.6% in 2020. Europe, which stands second, is expected to lose its share by the end of 2020 due to lack of interest shown by private investors.

In terms of services, illness is the leading segment by revenue and is anticipated to remain the largest segment until 2020. However, screening services represent the fastest growing segment.

The information presented in this review is based on a Transparency Market Research report, titled, ‘Urgent Care Centers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.’ 

Browse Research Report on Global Urgent Care Centers Market:
http://www.transparencymarketresearch.com/urgent-care-centers-market.html

Process Analytical Technologies for Pharmaceuticals Market Global Trends 2023

Stringent regulations monitor pharmaceutical product manufacturing. Since pharmaceutical products directly relate to health and life of an individual, every step of pharmaceutical product manufacturing is under strict vigil and is considered a crucial affair. In a report, titled “Process Analytical Technologies for Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2023,” Transparency Market Research (TMR) studies the importance of process analytical technologies in analyzing, evaluating, and controlling the pharmaceutical product manufacturing. 

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9028

In terms of service, the process analytical technologies market can be segmented into calibration, database management system (DBMS), and consultancy. Based on application, coating, lyophilization, evaporation, compression, packaging, raw material selection, and others constitute the key segments in the global process analytical technologies market. 

Regionally, the market is spread across Asia Pacific, Europe, North America, and Rest of the World (RoW). Currently, North America and Europe enjoy the leading share in the market as these regions boast sophisticated healthcare infrastructure. However, TMR predicts growth witnessed by the market in Asia Pacific and across a few emerging economies in RoW to outpace that witnessed in developed regions. The accelerating investment in pharmaceutical infrastructure and technologies across developing economies will create lucrative opportunities for the process analytical technologies market. 

Spurred by aforementioned factors, TMR projects the process analytical technologies for pharmaceuticals market to grow at a robust pace between 2014 and 2020. Growth witnessed by the market will be particularly high in developing economies as they exhibit higher spending on technological advancements. Furthermore, the market is expected to gain from the higher investment in research and development of novel therapeutics. Besides this, stringent approval process for drugs and medical devices will aid the expansion of the process analytical technologies market. 

Following the recent technological advancements, the advent of several new medical devices is expected in the forthcoming years. The launch of these devices is likely to bolster opportunities for the process analytical technologies providers. With government and international agencies mandating various tests during pharmaceutical product manufacturing, the demand for process analytical technologies is expected to rise considerably during the forecast period. 

On the flip side, the lack of skilled professionals, threat of false results and malfunctions, and high cost of instruments will pose challenge to the process analytical technological market. It is critical to mitigate these concerns for key players to enjoy sustainable growth through the course of the forecast period. 

Some of the companies operating in the global process analytical technologies market are Honeywell, Tektronix, Inc., Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific, Inc., Fluke Biomedical, and Carl Zeiss AG.

Browse Research Report on Global Process Analytical Technologies for Pharmaceuticals Market:
http://www.transparencymarketresearch.com/process-analytical-technologies-pharmaceuticals-market.html

Analysis of the Global Medication Management Market Trends and Forecast, 2016 - 2024

Global Medication Management Market: Overview 

The growing legal liabilities associated with medication errors have been reason enough for healthcare providers to invest in medication management systems. There is also a promising opportunity developing for medication management in homecare settings. While large multi-facility hospitals are the biggest users of medication management systems, smaller hospitals worldwide are warming up to the idea of streamlining their medication process as well. What works in the favor of the medication management market, however, is that implementation of such systems has become easier with the support of healthcare IT. The growing dependence of the aged—who comprised 11.7% of the global population in 2013—on healthcare providers to plan and dispense medication is further contributing to the revenue growth of the medication management market. 

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1663

Market data for medication management systems has been compiled based on sales and the corresponding revenue generated. Prices considered for the purpose of compiling data have are essentially averages taken from quotes provided by suppliers, distributors, and manufacturers. The report delves into the key segments of the medication management market by application, end use, and type. The size of key geographical markets has been derived via a summation of countries in each major region (North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America). 

Global Medication Management Market: Trends and Drivers 

With more evidence emerging about the ability of medication management systems to make medication error-free, efficient, and more accessible to patients, a noticeably favorable outlook toward the solution is developing. Besides, the contribution of automated medication dispensing systems in establishing decentralized medication management systems is enticing more healthcare providers to invest in the latter. The factors listed above are collectively enabling the global medication management market to post progressively higher growth every year. 

Medication management systems are deployed at private healthcare centers, multi-facility and specialty hospitals, and in homecare settings. This necessitates the use of medication management systems of different sizes, features, and capabilities. For instance, medication management systems designed for personal use are primarily programmed to organize a weekly medication schedule, setting reminders, and organizing regular visits by healthcare professionals. 

The market is currently witnessing strong demand for the following types of medication management systems: infusion solutions, point-of-care verification, medication analytics, medication technologies, and ADE surveillance. However, since it is still early days for the medication management market, a few complications still exist with their operation and maintenance. 

Global Medication Management Market: Segmentation and Vendor Landscape 

To dive into the second and third levels of the global medication management market, the report shears it down on the basis of the following criteria: type of medication management services and service provider type. Service providers such as private healthcare providers, hospitals, and others are analyzed in the report. 

The report also profiles the leading companies in the medication management market to trace their recent developments and milestones. The annual revenues of these companies, where available, have been provided in the report. Companies that either find a mention or are extensively profiled in the report include: CareFusion, Inc., B.Braun Melsungen AG, Baxter International, Inc., and Hospira, Inc. 

Browse Research Report on Global Medication Management Market:
http://www.transparencymarketresearch.com/medication-management-market.html

Dental Lasers to Play Pivotal Role in Enabling Global Dental Equipment Market touch US$7.6 bn by 2018

Transparency Market Research, a global market intelligence firm, has recently published a new market research report made available on the company website. The research study, titled “Dental Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” presents a detailed overview of the global dental equipment market, including market drivers and barriers, product segmentation, major geographical segmentation, and the competitive landscape of the market.According to the research study, in 2011, the global dental equipment market was valued at US$5.5 bn and is estimated to reach a value of US$7.6 bn by 2018, exhibiting a 4.70% CAGR between 2012 and 2018.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=223

Dental equipment refers to tools that are used by dental professionals while providing dental treatment to a patient. These tools assist the dental professionals in examining, restoring, removing teeth, and other dental treatments. These devices also help the dental professionals in manipulating tissues so as to get a proper visual access throughout the dental treatment. Several types of dental equipment find application in dental hospitals and clinics for dental ailments including gingival diseases and caries.

Technical advancements in treatment and diagnostic technologies, the growing global geriatric population, surging demand for cosmetic dentistry, increasing disposable incomes, and the booming dental tourism industry are some of the major factors that are expected to boost the demand for dental equipment throughout the forecast period globally. However, the high cost of advanced equipment, the growing refurbished dental equipment market, fluoridation, and taxes on medical devices are some of the factors hampering the growth of the global dental equipment market.

The global market for dental equipment has been segmented on the basis of type into hygiene maintenance devices, systems and parts, dental radiology equipment, laboratory machines, dental lasers, and other equipment. In 2011, the systems and parts segment led the overall market owing to the diverse application range of these products, followed by the dental radiology equipment segment. On the other hand, the dental lasers segment is expected to grow rapidly over the forecast period.

The global market for dental equipment has been divided on the basis of geography into Asia Pacific, Europe, North America, and Rest of the World. As per the study, North America leads the overall market for dental equipment. The rapid growth of this region can be attributed to the high prevalence of dental caries among the population. In 2011, the North America market was followed by Europe, which accounted for a share of 35% in the global dental equipment market in 2011. Asia Pacific is estimated to register a slow growth rate in the next few years.

Furthermore, the competitive landscape of the global market for dental equipment market has been elaborated in the last section of the research study. The analysis includes the company profile, contact information, inception details, products offered, financial overview, business policies, and recent developments if any. The prominent players operating in the global dental equipment market include Biolase Inc., GC Corporation, Planmeca Oy, CareStream Health, Dentsply International Inc., Ivoclar Vivadent AG, Sirona Dental Systems, Henry Schein Inc., Danaher Corporation, and A-dec Inc.

Browse Research Report on Dental Equipment Market:
http://www.transparencymarketresearch.com/dental-devices-market.html

Home Healthcare Software Product Market Global Industry Size and Share 2024

Global Home Healthcare Software Market: Overview

Home healthcare is a wide segment consisting of various software, products and services which are provided at patients’ home. The trend observed globally is the shift of treatment from hospitals to homes in order to save expenses and gain cost effectiveness. The convenience and cost effectiveness offered by the home healthcare services and treatments over hospital treatment are the driving forces for this market. In the home healthcare market third party service providers are witnessing huge demand for better treatment quality and trained professionals. Asian countries such as Japan, India and China show high demand for home healthcare, as they contain a growing aging population. North America is also showing constant growth in the home healthcare market as reimbursement is offered on specific devices and health policies in the U.S.

Get Research Report with ToC on Home Healthcare Software Market:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12188

Cost & convenience, increasing awareness, rising prevalence of diseases & the growing aging population, technical advancements in healthcare segment and rising incidence of chronic diseases globally are some driving forces for global home healthcare market. Some of the factors restraining the growth of the home healthcare device market include changing nature of reimbursement policies, limited coverage for home healthcare devices, changing technologies and regulatory obstacles for the new era devices. Players in the home healthcare market can seek opportunities in cost efficient devices through strategic aligning and telehealth patient monitoring

Global Home Healthcare Software Market: Segmentation

The home healthcare software market is segmented on the basis of type of equipment, type of service provided and region. On the basis of type of equipment, the home healthcare market is segmented into monitoring equipment, therapeutic equipments and mobility assist & other equipment. This monitoring equipment segment is further segmented into home diabetes care devices, home holter monitors, home pregnancy/fertility tests, heart rate meters, home - apnea & sleep monitors, home patient monitors and other home patient monitors. Home healthcare therapeutic equipment segment is further segmented into home respiratory therapy equipment (medical ventilators and accessories, medical nebulizer kits and devices, continuous positive airway pressure products and oxygen delivery systems), home IV equipment, home insulin delivery devices, home dialysis equipment, hearing aids market and other home therapeutic equipment. Mobility assist equipment segment is further segmented into wheelchairs and related devices, walking assist devices and home medical furniture.

Home healthcare services market is segment into respiratory therapy services, infusion therapy, unskilled home healthcare and rehabilitation service providers (speech therapy, occupational therapy and physical therapy). On the basis of region, the home healthcare software, product and service market is segmented into North America, Europe, Asia Pacific and rest of the world (RoW).

Global Home Healthcare Software Market: Competitive Dynamics

Some major players in the home healthcare software, product & service market are Abbott Laboratories, Air Liquid S.A., Amedisys Inc., American Homepatient Inc., Apria Healthcare Group inc., Baxter International Inc., Bayer Ag, B. Braun Melsungen Ag, Carefusion Corporation, Coloplast A/S, Convatec Inc., Covidien Plc., C.R. Bard Inc., Eli Lilly and Company, Fresenius SE & Co Kgaa, GE Healthcare, Gentiva Health Services Inc., Philips Healthcare, Invacare Corporation, Lincare Holdings Inc., Medtronic Inc., Novo Nordisk, Siemens Healthcare, Sunrise Medical Inc., and Teleflex Incorporated, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Browse Research Report on Global Home Healthcare Software - Product & Service Market:
http://www.transparencymarketresearch.com/home-healthcare-software-product-service-market.html

Global Resorbable Implants Market Segment and Industry Size 2016 to 2024

A man made medical device which supports, enhances or replaces the existing, damaged or missing biological structure, by implanting it into the human body is called as implants. There are several types of implants available in the market with a wide range of specialties. One of which is Resorbable implant. These implants have special and distinguished property. Such implants are biologically assimilated into the body slowly and is not required to be removed after a stipulated time. They have several dental, orthopedic and vascular applications. Resorbable implants are the prosthetic in nature and are used to regularize the physiological function in the human body. The worldwide increasing life expectancy and declining mortality rate have resulted in increased population of the age group above 60 years. Hence globally the geriatric population is growing at a faster rate than any other age group. The demand of such a population is fast, safe and effective treatment for their age related medical problems. Several applications of such implants into the orthopedic and dental field has also triggered the demand and usage owing to appreciable patient outcome. This has gripped the consideration of resorbable-implant companies to invest into such a market. Also key players are keenly interested in developing and commercializing the implants that are more cost effective and which will fulfill the geriatric patient demand.

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15320

The dental treatment including the usage of implants has a wide range of medical conditions like reconstruction of craniomaxillofacial bone due to trauma and facial prosthetic to correct the facial deformities, Mandibular fixation etc. The orthopedic treatment with the usage of resorbable implants includes Hand surgery, Bankart procedure, Trauma, Scaphoid fractures, Ankle ligament lesions.

Examples of resorbable implants are resorbable stent, resorbable mesh, resorbable band, resorbable scaffolds, and resorbable tethers. Resorbable Stents are usually used in cardiac and vascular indication whereas resorbable mesh are used in general surgeries for wound healing. Resorbable bands scaffolds and tethers have orthopedic applications.

The material most commonly used in resorbable implants are polyglycolic acid, polylactic acid, polydiaxonone, poly-L-lactic acid, poly-D-lactic acid, polycaprolactone, poly beta hydroxybutyrate. Polyglycolic acid and Polylactic acid are most popular amongst the orthopedic implants due to its unique mechanical and biocompatible property which is mandatory for its application. The upcoming materials used in resorbable implants are poly-L-lactic acid and poly-D-lactic acid. The L isomer is not only biologically inert but also biodegradable and biocompatible which helps to initiate the neocollagenesis process. As a result collagen builds up at the site of injection over the time and the poly-L-lactic acid microparticles is metabolized to carbon dioxide and water and expelled through respiratory system. These materials are usually used in the screws and plates used in orthopedic indications.

Several factors which are majorly driving the growth of resorbable implants market are growing concern for chronic diseases, rising geriatric population, growing disposable incomes and high level of healthcare .In addition, increasing areas of application mainly in medical and dental streams will contribute to the market growth. The pipeline and the future advancement in resorbable implants is anticipated to have a robust market growth. However time consuming approval procedures of implants by regulatory bodies, reimbursement issues and high cost of treatment would hamper the growth of resorbable-implants market.

The global resorbable implants market is segmented based on product type as Resorbable Stent, Resorbable Mesh, Resorbable Band, Resorbable Scaffolds, and Resorbable Tethers.

The global resorbable implant market is segmented based on material type as Polyglycolic acid, Polylactic acid, Polydiaxonone, Poly-L-Lactic acid, Poly-D-Lactic Acid, Polycaprolactone, Poly beta Hydroxybutyrate.

The global resorbable implants market is segmented based on application as Orthopedic Surgeries, dental Surgery, vascular Surgery and General Surgery.

The global resorbable implants market is segmented based on end user as Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.

Depending on geographic region, resorbable implants market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

By resorbable implants type, stents and mesh are the choice of implants among the relatively limited resorbable implants that are approved in the market. The bands, scaffolds and tethers are popular amongst the orthopedists and dentists and holds noticeable share due to its easy availability and lower cost.

North America region holds the largest share of the global resorbable implant market, in terms of revenue due to the stronger health care infrastructure and considerable pool of the key manufacturers. Following North America Europe is the second largest resorbable implants market owing to technological advancement in the region. In addition, high disposable income and increase in geriatric population in developing countries like India and China, are expected to drive the growth resorbable implants market in Asia.

Key companies operational in resorbable implants market are Proxy Biomedical Ltd, KLS Martin LP., Bionx Implants Inc., Tornier, Inc., Degradable Solutions AG, Integra Life Sciences Corporation, Johnson & Johnson Services, Inc.,

Browse Research Report on Global Resorbable Implants Market:
http://www.transparencymarketresearch.com/resorbable-implants-market.html

Cardiac Assist Devices Market - Global Industry Analysis and Trends - 2019

In 2012, over 30% of all global deaths could be traced back to cardiovascular diseases (CVDs). An alarming rise in the incidence of CVDs is arguably the biggest factor driving the growth of the global cardiac assist devices (CAD) market, says Transparency Market Research (TMR) in a new report, which is titled, “Cardiac Assist Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.” The demand for cardiac assist devices will also be helped further by a grave shortage of donor hearts, making heart transplantation only a rare possibility. The report studies the growth prospects in this rapidly emerging market by focusing on specific aspects such as drivers, restraints, challenges, and opportunities. The size of the market is estimated by the demand-based revenue generated via sales of cardiac assist devices.

Get Research Report with TOC: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1810

Patients suffering from cardiovascular diseases are typically advised to consider cardiac assist devices to correct the blood pumping efficiency of the heart. These mechanical pumps work in conjunction with the heart to help an optimum blood flow. The three types of cardiac assist devices (CADs) commonly used are: Intra-aortic balloon pumps (IABPs), ventricular assist devices, and total artificial heart. The ventricular assist devices can either be designed to work with the left or right ventricle. Of these, left ventricular assist devices (LVAD) are the highest sold products and will likely remain popular through the forecast period of the report. With rapid advancements taking place in cardiac assist devices, it is projected that CADs could soon reach a phase where heart transplantation can be entirely avoided. 

The report states that the cardiac assist devices market in North America currently stands as the largest on account of the region reporting a high rate of heart failure cases. Moreover, most new technological developments hit the U.S. first, which makes the uptake of CADs higher in the country as compared to many other markets. The impact of all of these factors is sewn together by the high degree of awareness among patients regarding the benefits of cardiac assist devices and CAD implantation being covered by reimbursement.

Europe trails North America in revenue generation in the cardiac assist devices market. The region reports the second-highest prevalence of cardiovascular diseases among people above the age of 65 years. The report recommends companies in the cardiac assist devices market to also focus on densely populated countries such as China and India where the median age is rising progressively. These countries also present a white space that can be filled in by CADs thanks to a substantial number of underserved cardiac patients. 

Companies that are currently at the forefront of the global cardiac assist devices market are ABIOMED, Inc., Berlin Herat GmbH, Thoratec Corporation, MAQUET GmbH & Co. KG, HeartWare International, Inc. Teleflex Incorporated, and SynCardia Systems, Inc.

Browse Research Report on Global Cardiac Assist Devices Market:
http://www.transparencymarketresearch.com/cardiac-assist-devices.html

Ventilator Accessories Market Size, Share and Forecast 2016 - 2024

Ventilators are critical life-support devices that provide respiratory therapy to millions of patients every single day. The ventilator accessories market unveils the characteristics of an increasingly mature market with innovative brands & unique product differentiation in order to secure competitive advantage. The ventilation accessories segment includes flow sensors, breathing sets, expiratory valves, endotracheal tubes, breathing circuits, humidifiers, interfaces, masks & lot more. The relatively inclusive range of end use sectors and specialist applications for innovative ventilator accessories represents a supportive factor in terms of the long term market growth. Large medical device manufacturers are majorly focused on launching novel products in order to accomplish development in the global ventilators market. Companies are also more attentive on collaboration by acquiring domestic and international players to expand their product portfolios and boost their distribution channels in emerging markets. High-tech advancement is another key factor for manufacturers to improve technologies and thus prevent respiratory illness and reduce the time spent on other ventilation procedures.

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15299

Drivers & Restraints

Rising elderly population, growing prevalence of respiratory disorders, and rising number of preterm births are predictable to fuel the growth of ventilators accessories market in the forecast period. Ventilator accessories market growth has been driven by increasing in sales of portable and mechanical ventilators. Furthermore there is also an increase in the relevance of hospitals, medical emergency services and rehabilitation centers can be expected to rise in the demand for ventilators. Industry experts design these accessories utilizing the high grade standard material with high-end technology. Manufacturers are mainly focused for the highest possible patient safety and ease of use. Growing per capita income, extensive R&D investments in the healthcare industry by top market players, rising demand for advanced front-line technologies, and expansion of private hospitals and rehab-centers in remote areas are the major factors driving growth of the ventilators accessories market globally. Also, lack of access to primary care in developing regions is comparatively driving sensitive demand for urgent respiratory care utilization. Patient safety and operator control safety is the prime concern which has been regulated by the few official authorities which has executed huge challenges for the medical device manufacturers. New materials may bring together biocompatibility and circuitry issues.

Global Ventilators Market: Segmentation

The Global Ventilators Market market can be segmented as follows:

Global ventilator accessories market by Product Type

• Flow sensors
• Breathing sets
• Expiratory valves
• Endotracheal tubes
• Breathing circuits
• Humidifiers
• Interfaces and masks
• Others

Global Ventilators Market, by End User

• Hospitals
• Ambulatory Surgery Centres
• Clinics
• Emergency Medical Services
• Long term care centres 
• Global Market: Regional Outlook

Geographically, the global ventilator accessories market is segmented into five regions, namely North America, Latin America, Europe, Asia Pacific & the Middle East and Africa (MEA). North America (U.S) is the largest regional segment of the overall ventilator market, followed by Europe region. Currently Asia-Pacific region has also enhanced the growth rate during the forecast period. The rate of efficiency is mainly attributed to the geriatric population worldwide, rising incidences of cardio-vascular & respiratory diseases, extensive growth in healthcare expenditure, and rapidly growing healthcare industry worldwide. These regions are expected to generate the fastest growth rates potentially.

Global Ventilators Market: Key Players

The key players in the Ventilators market are

• Drägerwerk AG & Co. KGaA
• GE Healthcare Ltd.
• Siemens Healthcare
• ResMed Inc.
• Fisher & Paykel Healthcare Corp. Ltd.
• Hamilton Medical AG
• Invacare Corp.
• CAS Medical Systems Inc.
• Nihon Kohden Corp.
• Nonin Medical Inc.
• Criticare Systems Inc.
• Spacelabs Healthcare Inc.
• Nellcor Puritan Bennett LLC
• ALARIS Medical Systems Inc.
• Criticare Systems Inc.
• Masimo Corp.
• Welch Allyn Inc.

The global market for ventilator accessories market is further expected to witness significant growth over the report’s forecast period owing to the rapid and consistent technological innovation in these medical devices and the rising cases of chronic respiratory disorders among people worldwide.

Browse Research Report on Global Ventilator Accessories Market:
http://www.transparencymarketresearch.com/ventilator-accessories-market.html

Single Port Surgical Platform Market Global Industry Trends and Forecast 2024

Single port surgical platform (SPSP) is a minimal invasive laparoscopy technique in which, a single incision is made on the body through single trocar which have multiple ports or single skin incision site with multiple facial incisions that have an individual trocar, are used to conduct the surgery. Single port surgical platforms are also called Single Port Access Surgery (SPA), Single-Incision Laparoscopic Surgery (SILS), and Laparo-endoscopic Single-Site Surgery (LESS). Normally, in abdominal surgeries, large incisions are made to conduct the surgery. Although, they are effective but they usually cause postoperative pain, wound infections, and prolonged hospitalization. Current rate of incisional hernia is 4-18% and wound infections are 2-25% in the U.S whereas, in case of conventional laparoscopic surgeries, multiple incisions are made on the body to conduct the surgery. To overcome the above challenges, companies are focusing on developing the novel single-port surgical platform, which creates single incision on the body. This surgical platform also helps in speedy recovery, small incisions, and are less prone to infections and pain conditions. In addition to these, it does not leave any scars on the body after the surgery.

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15263

The market is driven mainly by factors such as technological innovations, increase in adoption of SPSP, growing preference towards minimally invasive surgery process, and exploration of their utility in other applications Ex: General Surgery, Gastroenterology, Urology, Gynecology and Bariatric Surgery. Increasing preference towards scar-less slimming surgeries is a major factor responsible for boosting the market growth. This platform allows surgeons to conduct surgeries in the abdominal cavity by accessing through small holes. Furthermore, SPSP reduces treatment costs by reducing hospital stay of the patients. Hence, patients and surgeons are prefer SPSP as compared to others. The major constraints of this market are high cost, lack of skilled professionals, and triangulation problems. The single port surgical platform (SPSP) is segmented based on its application and technology.

Segmentation by Application

• General Surgery
• Gastroenterology
• Urological
• Gynecological
• Bariatric

Segmentation by Technology

• Robot/ Remote controlled Assisted
• Manual – Assisted

New products are being launched into the market to alleviate the disadvantages of the current SPSP platforms. SPSP is a lucrative segment in the laparoscopic surgeries, due to its technical aspects and patient benefits. On the basis of application, SPSP is mainly used in Bariatric surgeries. However, they are gaining traction of the other application areas such as gynecology, urology, gastroenterology, and general surgery due to its advantages.

On the basis of its technology, the manual assisted SPSP holds major market share as compared to robot-assisted. In future, robot/ remote controlled technology is expected to dominate the market because surgeons can perform the complex surgeries in a more accurate and flexible way than the conventional surgery process by using the robot/ remote controlled technology

Recently, Intuitive surgical, a U.S.-based company, received FDA approval for its da Vinci Sp single port robot-assisted surgical system.

SPSP is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is holds a major market share on the basis of application of the SPSP owing to factors such as spending power of the people and introduction of new technologies into the market. Asia-Pacific markets are growing relatively fast due to cost effective surgeries and advancements in healthcare infrastructure.

Key players in this market are Covidien, Applied Medical, Ethicon, Olympus Gyrus-ACMI, Novare Surgical, Cambridge Endo, Karl Storz, Intutive surgical, Fortmedix Surgical, and Trans Enterix. The market is relatively dominated by major players however, new players are trying to hold a major part of the market share by developing innovative products.

Browse Research Report on Global Single Port Surgical Platform Market:
http://www.transparencymarketresearch.com/single-port-surgical-platform-market.html

Glenoid Implant System Market Trends and Global Industry Share Up to 2024

Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called Glenoid. Implanting the glenoid in a proper orientation is essential for long-term stability of the prosthesis. A malpositioned glenoid may have compromised fixation due to inadequate bony support or incomplete implant seating and may be subjected to increased torques on the fixation surface. The other causes for Glenoid implants are Osteoarthritis, Rheumatoid Arthritis, degenerative arthritis, Rotator Cuff Tear Arthroplasty, Avascular Necrosis, and Severe Fractures etc. According to the Agency for Healthcare Research and Quality, about 53,000 people in the U.S. have shoulder replacement surgery each year. Implantation of a glenoid component is not advised if the glenoid has good cartilage, the glenoid bone is severely deficient, and the rotator cuff tendons are irreparably torn. Glenoid Implants are available in different size, such as small, medium, large and XL. Glenoid involvement in degenerative arthritis varies depends on the type of arthritic process affecting the glenohumeral. For Instance, inflammatory arthritis is associated with central glenoid erosion. The extent and location of glenoid wear should be assessed preoperatively with axillary radiographs, axial CT scans and through the glenohumeral joint, or 3D CT reconstructions.

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15236

Achieving long-term fixation of the glenoid is a primary goal in total shoulder arthroplasty. Several methods of fixation have been attempted, including cemented, noncemented, and hybrid or minimally cemented devices. Cemented pegged and keeled components are used most commonly and are provide the most predictable fixation. Noncemented glenoids rely upon mechanical interlock and biologic integration, typically by screw fixation or a combination of screw or press-fit pegs, or both, to achieve an initial fixation that facilitates long-term bone in-growth/on-growth. According to center of disease control and prevention the prevalence of diagnosed arthritis is expected to increase among US population in the coming decades. By the year 2040, an estimated 78 million adults aged 18 years and older will have diagnosed with arthritis, compared with the 52.5 million adults in 2010-2012.

Glenoid Implant System Market: Drivers and Restraints

Factors such as Growing prevalence of symptomatic shoulder arthritis, increased patient awareness, technological advancement and expanded medical education and surgeon adoption of total shoulder replacement will fuel the overall glenoid implant market globally. According to National Health Interview Survey, 22.7 million (9.8% of all adults) have arthritis and arthritis-attributable activity limitation. Factors such as glenoid component loosening, pricing pressure, improper handling of implants are the factors will hinder the total glenoid implant market globally. Glenoid loosening is associated with increased pain, decreased shoulder function, and the need for revision surgery. 

Glenoid Implant Systems Market: Segmentation

The global Glenoid implant systems market is classified on the basis of product type, Size, end user and regional presence.

Segmentation based on product type:

• Pegged Glenoids
• Keeled Glenoids

Segmentation based on Size:

• Small
• Medium
• Large
• XL

Segmentation based on end user:

• Hospitals
• Clinics
• Orthopedic Surgery Centers

Glenoid Implant Systems Market: Regional Overview

Geographically, the global glenoid implant systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the glenoid implant systems market due to rising obese population. North America is followed by Europe and Asia Pacific. Asia Pacific is expected to grow at a highest rate due to fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people. Glenoid Implant device markets experienced a slowdown in 2012 in Japan, caused by reimbursement protocols instituted by the Japanese government.

Glenoid implant Systems Market: Key Players

Some of the major players operating in the market for global Glenoid implant are Smith & Nephew, Stryker, Zimmer, Tornier, Inc., Biomet, Exactech, Lima Corporate, Arthrex, Inc., Integra LifeSciences, DePuy Synthes, while there are a range of other smaller players as well. DePuy Synthes and Tornier represent more than half of the total market size due to its most diversified and innovated portfolios. DePuy and Tornier are expected to be the leading players in the arena for another five years

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Browse Research Report on Global Glenoid Implant System Market:
http://www.transparencymarketresearch.com/glenoid-implant-system-market.html

Telemonitoring Systems Market Can Transform Quality of Home Healthcare

Healthcare monitoring systems have been an integral part of the patient care services since a very long time. They are used to observe the symptoms, condition and other medical parameters of the patient. It is performed by measuring the vital medical parameters of the patient such as the heart rate, blood pressure, blood sugar level, etc. Telemonitoring systems are the medical devices used for the remote diagnosis, examination and monitoring of the patients by the clinicians. 

Get Sample Research Report with TOC: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15176

Telemonitoring systems allow the physicians and doctors to monitor the patient’s vital statistics at any given time. The rapid advancements in the information and visualization technology have provided new opportunities in the telemonitoring systems market. The telemonitoring systems enable the healthcare providers to provide effective and timely medical aid to the patients before it turns into a bigger problem. The data collected through monitoring must be analyzed thoroughly for suitable treatment measures. People who do not have access to high end hospital care due to lack of proper transportation or are unable to visit the doctor frequently due to critical conditions, telemonitoring systems have facilitated them to gain access to enhanced healthcare facilities, thus reducing the morbidity  and mortality rates. Telemonitoring systems are used for the management a variety of disorders. For example, patients with heart ailments can have their blood pressure and weight monitored on a daily basis. Any undesirable sudden change in the blood pressure/flow or weight can reflect a need to attend the possible worsening condition. If diagnosed on time, the treatment is more likely to be easily managed and the chances of hospitalizations are reduced. Diabetic patients can measure their blood glucose levels regularly and sustain these levels within a healthy range.  

The telemonitoring systems market is mainly driven by the incidence and prevalence rate of diseases such cardiovascular disease, chronic obstructive pulmonary disease (COPD), diabetes, etc. Moreover the demand of better measures for remote monitoring of patients and integration of information technology and monitoring devices have also propelled the market for telemonitoring systems. This integration has benefitted the patients with adequate monitoring at the comfort of home and are reducing the number of hospitalization and hence promoting efficient healthcare at home. High pool of geriatric population is also the major driver for the telemonitoring systems market.

The Global Telemonitoring Systems market is segmented on the basis of product type, end-user and regional presence:

Segmentation based on product type

• COPD  Telemonitoring System
• Glucose Level Telemonitoring System
• Blood Pressure Telemonitoring System
• Cardiac Telemonitoring System
• Others 

Segmentation based on End-user

• Home Care
• Long-term Care Centers
• Hospice Care 

With the growing geriatric population leading to increase in the various disease indications, the telemonitoring systems market is also expected to increase rapidly. Moreover substantial rise in the healthcare spending and upsurge in disposable income will boost the telemonitoring systems market during the forecast period.

Geographically the telemonitoring systems market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.

North America is anticipated to be the largest market for telemonitoring systems. The demand for telemonitoring systems market in the U.S. is driven by the country’s strong economy and the rising trend of home nursing facilities and hospice care. Other factors attributable to market growth include increasing patient awareness, technological innovations, high investments in research and development, and the increasing disease incidences. The telemonitoring systems market is also expected to witness strong growth in Europe due to advantages such as accurate diagnosis with easy to use technology and ease in data sharing. Asia-Pacific is also expected to be the promising market for AVS technology in the near future due to developing economies and presence of large under-served patient population. Latin America also offers immense growth potential in the near future due to extensive development of health care infrastructures, increasing population, and rising government funding. However, high costs for set-up and maintenance can be a major restraint of the market in regions such as Middle East & Africa.

Some major companies in the telemonitoring systems market are Abbott, Cisco Systems, Inc., DigiO2 International Co. Ltd., GE Healthcare, Honeywell HomeMed, Mindray Medical International Limited, Philips Healthcare, Qi Imaging, LLC, Siemens Healthcare, and Telehealth Solutions.

Browse Research Report on Global Telemonitoring Systems Market:
http://www.transparencymarketresearch.com/telemonitoring-systems-market.html

Single-use Bioreactors Market Global Analysis in Pharmaceutical Industry in 2019

A new market intelligence study by Transparency Market Research offers a thorough overview of the global single-use bioreactors market. The research study, titled “Single-use Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019,” presents insights into the key growth prospects, latest trends, and opportunities in the market. The historical data, past performance, and expected growth rate and statistics have been included in the research study to offer a clear picture of the market. 

Get Sample Research Report with TOC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2108

Single-use bioreactors have been gaining traction in recent years as they offer several benefits over conventional bioreactors. Single-use bioreactors ensure safety and do not require any kind of sterilization or cleaning. Moreover, these bioreactors help in saving time and operational cost, thus augmenting the growth of the market. Key types of single-use bioreactors include non-stirred disposable bioreactors, stirred flexible disposable bioreactors, stirred rigid disposable bioreactors, and non-stirred flexible bioreactors. The rising number of diseases across the globe and increasing demand for drugs to treat the patients is the primary factors estimated to boost the demand for single-use bioreactors in the forecast period. 

Ease in the cultivation of marine organisms and reduced complexity of automation are the primary factors driving the global single-use bioreactors market. In addition, the increasing popularity of subs among several biopharmaceutical companies and swift growth of the biologics market are expected to create new opportunities in the global market. However, several regulatory issues related to single-use bioreactor and concerns associated with extractables and leachables are projected to restrict the growth of the global single-use bioreactor market in the coming years.

On the basis of geography, the global single-use bioreactors market can be classified into North America, Europe, Asia Pacific, and Rest of the World. Among these segments, Europe and North America account for a massive share in the global market at present as most of the prominent biopharmaceutical companies are located in these two regions. On the other hand, Asia Pacific is projected to witness significant growth in the next few years as several leading companies are setting up their manufacturing units in this region and driving the demand for disposable bioreactors.

Key players operating in the global market for single-use bioreactors include Merck Millipore, PBS Biotech, GE Healthcare, Xcellerex, Cellexus Limited, Sartorius Stedim Biotech, and Thermo Fisher Hyclone. The improved returns on investment for startups and small companies are expected to encourage the participation of new entrants and fuel the growth of the overall market in the next few years.

Browse Research Report on Single-use Bioreactors Market:
http://www.transparencymarketresearch.com/single-use-bioreactors-market.html

Wound Dressings Market: Advanced Wound Dressing Boosted by Increasing Healthcare Expenditure

The global wound dressings market is highly fragmented in nature due to the stakes of numerous global and regional players in the industry. The top three players in the market accounted for approximately 52% of the overall market value in 2013, finds Transparency Market Research (TMR) in a new study. These three players are Smith & Nephew plc, Mölnlycke Health Care, and ConvaTec Inc. 

“Efficient distribution networks, product differentiation, and supply competency play a central role in determining the market position of players. Companies are engaging in mergers and acquisitions to gain a competitive edge over others in this highly competitive marketplace,” says the author of the report.

The global wound dressings market was valued at US$8.11 bn in 2015 and is poised to reach US$10 bn by 2020, rising at a CAGR of 4.5% from 2014 to 2020. Traditional wound dressings will continue to dominate the market in terms of revenue until 2020. However, due to rising awareness about the benefits, the advanced wound dressings segment is expected to expand at a significant CAGR of 7.6% over the forecast period.

You can download a sample report
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=453

Asia Pacific to Emerge as Significant Market for Wound Dressings Manufacturers

The global wound dressings market is broadly classified into traditional wound dressings and advanced wound dressings. Asia Pacific will continue to be the leading traditional wound dressings market until 2020, representing nearly 32% of the global market value. However, Rest of the World will expand at an impressive CAGR during the same period. On the other hand, North America will continue to dominate the advanced wound dressings market by revenue until 2020. Due to rising per capita expenditure on healthcare and improving economic conditions, Asia Pacific will rise at a CAGR of 9.3% between 2014 and 2020.

Rising Geriatric Population to Augment Growth of Wound Dressings Market

The rise in geriatric population can potentially increase the demand for medical services three to five folds and trigger the prevalence of non-communicable diseases. This factor boosts the need for surgical procedures, consequently propelling the growth of the global wound dressings market. Moreover, the rise in life expectancy of the population worldwide is increasing the demand for healthcare. This, in turn, is fuelling the demand for wound care dressings.

“New product development and novel therapies are helping reduce wound-related infections among patients while also cutting down on healing time. These benefits are conducive to the greater uptake of advanced wound dressings,” says a TMR analyst. Improvements in synthetic dressing materials, recombinant factors, endovascular techniques, and bi-layered human dermal substitutes are positively influencing the growth of the global market. Other factors driving the market are the rising incidence of chronic diseases and wound infections, increasing per capita spending on healthcare, and growing patient awareness regarding personal health.

Reluctance in Adoption of Novel Therapies to Impede Revenue Growth of Wound Dressings Market

The advanced wound dressings are only affordable amongst the affluent population. Asian markets being price sensitive have significant inhibitions on investing in advanced wound care. This limits the adoption of the advanced wound dressings. Moreover, reluctance in adoption of novel wound care technologies amongst healthcare providers and physicians, especially in Europe and Asia, is stagnating the sales of advanced technologies. Furthermore, the absence of a favorable reimbursement scenario is hampering the wide-scale adoption of wound care dressings. These factors, collectively, are restraining the growth of the global wound dressings market. However, manufacturers are increasingly focusing on the development of combination dressings to strike a balance between cost and functionality. In the foreseeable future, this factor is likely to augur well for the growth of the market.

Browse Research Report on Global Wound Dressings Market:
http://www.transparencymarketresearch.com/wound-dressing-market.html